osimertinib
astrazeneca
['osimertinib']
dr. j riess (uc davis) doing a nice job putting new data on egfrm+ into context. points out subset of pts w/egfrm+ benefit from io, anti-vegf may help; &amp; egfr tki zorifertinib looks vy good in cns dzs 1st gen agents, but so does osimertinib, which we already have. #asco23 
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website